Molecular Mechanisms Against Successful Weight Loss and Promising Treatment Options in Obesity

Zsolt Szekeres1, Eszter Szabados2, Anita Pálfi2

  • 1Department of Laboratory Medicine, Medical School, University of Pecs, H-7624 Pecs, Hungary.

Biomedicines
|August 28, 2025
PubMed

Insights

Obesity involves complex molecular mechanisms like metabolic memory and epigenetics that hinder weight loss. Novel therapies show promise, but long-term efficacy requires further study for effective obesity management.

Area of Science:

  • Molecular mechanisms of obesity
  • Metabolic disorders
  • Endocrinology

Background:

  • Obesity is a complex health issue with multifactorial causes including lifestyle, genetics, and neuroendocrine factors.
  • Despite interventions, sustained weight loss remains a significant challenge.
  • Understanding molecular mechanisms is crucial for developing effective obesity treatments.

Purpose of the Study:

  • To review current knowledge on molecular mechanisms impeding weight loss.
  • To summarize emerging therapeutic strategies for obesity management.
  • To provide insights into the complexities of obesity treatment.

Main Methods:

  • Comprehensive literature review of PubMed, Scopus, and Web of Science databases.
  • Inclusion of peer-reviewed original articles, systematic reviews, and meta-analyses.
  • Focus on studies published within the last ten years (2015-2025), with allowance for historically significant works.

Main Results:

  • Obesity is a chronic condition requiring personalized, multidisciplinary approaches.
  • Key molecular mechanisms include metabolic memory, epigenetics (DNA/histone modifications, microRNAs), and adipose tissue dysfunction.
  • Adipose tissue dysfunction contributes to inflammation and insulin resistance, exacerbating obesity.
  • The balance of adipocyte types (white, beige, brown) influences energy regulation.
  • Novel medical interventions show potential in counteracting weight loss barriers.

Conclusions:

  • Combined interventions (diet, exercise, pharmacotherapy) offer potential for obesity treatment.
  • Long-term efficacy and safety of current and novel interventions need further investigation.
  • Personalized and multidisciplinary strategies are essential for effective obesity management.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
350
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.8K